Tag: RPMO2

ProSomnus Announces Significant Scientific, Technical, and Advocacy Updates
Clinical Insights & Research Dental Sleep Medicine Industry News Professional Practice Technology

ProSomnus Announces Significant Scientific, Technical, and Advocacy Updates

ProSomnus Sleep Technologies announced the formation of its inaugural Medical Advisory Board, significant enhancements to its RPMO₂ platform, and growing clinical evidence supporting precision oral appliance therapy (OAT), including results from the FLOSAT study. These advancements will be highlighted during the company’s participation at CHEST 2026, October 19-21, 2026, in […]

prosomnus monitair
Dental Sleep Medicine Partnerships Sleep Apnea

ProSomnus and MonitAir Collaborate to Enhance Connected Care for OSA

ProSomnus Sleep Technologies (“ProSomnus”), pioneer of Smart Sleep Medicine™, and MonitAir, LLC (“MonitAir”), the premier digital health and tele-monitoring platform for sleep medicine announced a collaboration to support connected, longitudinal and personalized care for patients with obstructive sleep apnea (OSA). Through this collaboration, healthcare providers who prescribe a ProSomnus RPMO₂ […]

ProSomnus Announces Record Revenues as it Emerges from Reorganization
Dental Sleep Medicine Industry News Product News Technology

ProSomnus Announces Record Revenues as it Emerges from Reorganization

ProSomnus Sleep Technologies announced record revenues for the quarter that ended June 30, 2024, as it formally emerged from reorganization on August 5, 2024. Revenues for the second quarter totaled a record $9.1 million reflecting increasing orders for the Company’s precision intraoral medical devices. These quarterly results reflect a 22% […]